Skip to main content
Erschienen in:

25.11.2021 | COVID-19 | Original Article Zur Zeit gratis

Gout during the SARS-CoV-2 pandemic: increased flares, urate levels and functional improvement

verfasst von: Juan Salvador García-Maturano, David Eduardo Torres-Ordaz, Miguel Mosqueda-Gutiérrez, Citlallyc Gómez-Ruiz, Aarón Vázquez-Mellado, Alicia Tafoya-Amado, Ingris Peláez-Ballestas, Rubén Burgos-Vargas, Janitzia Vázquez-Mellado

Erschienen in: Clinical Rheumatology | Ausgabe 3/2022

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Gout is the most common inflammatory arthritis, but was not considered in most COVID-19 and rheumatic diseases reports. Our aim was to describe changes in clinical data, treatment, function and quality of life for gout patients during COVID-19 pandemic.

Methods

Prospective, descriptive and analytical study of 101 consecutive gout (ACR/EULAR 2015) patients from our clinic evaluated during pandemic by phone call (n=52) or phone call + face-to-face (n=68) that accepted to participate. Variables are demographics, clinical and treatment data, HAQ, EQ5D questionnaires and COVID-19-related data. Patients were divided in two groups: flare (n=36) or intercritical gout (n=65) also; available pre-pandemic data was obtained from 71 patients. Statistical analyses are X2, paired t-test and Wilcoxon test.

Results

Included gout patients were males (95.8%), mean (SD) age 54.7 (10.7) years and disease duration 16.4 (9.8) years; 90% received allopurinol, 50% colchicine as prophylaxis and 25% suspended ≥ 1 medication. Comparison of pre-pandemic vs pandemic data showed > flares (4.4% vs 36%, p=0.01), more flares in the last 6 months: 0.31 (0.75) vs 1.71 (3.1), (p=0.004 and > urate levels: 5.6 (1.7)vs 6.7 (2.2) mg/dL, p=0.016. Unexpectedly, function and quality-of-life scores improved: HAQ score 0.65 (2.16) vs 0.12 (0.17), p= 0.001. Seven patients were COVID-19-confirmed cases; they had significantly more flares, higher urate levels and lower allopurinol doses and two died.

Conclusions

In gout patients, flares were 9 times more frequent during pandemic also, they had increased urate levels but led to an unexpected improvement in HAQ and functionality scores. Resilience and lifestyle changes in gout during COVID-19 pandemic require further studies.
Key Points
• COVID-19 pandemic is associated with 4 times more flares in gout patients.
• Increased flares were also seen in previously well-controlled gout patients.
• Increased serum urate levels were also found in gout patients during pandemic.
• In our gout clinic, 8/101 patients were diagnosed as COVID-19+, and two of them died.
Literatur
7.
Zurück zum Zitat Strangfeld A, Schäfer M, Gianfrancesco MA, Lawson-Tovey S, Liew JW, Ljung L et al (2020) Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry. Ann Rheum Dis -219498. https://doi.org/10.1136/annrheumdis-2020-219498 Strangfeld A, Schäfer M, Gianfrancesco MA, Lawson-Tovey S, Liew JW, Ljung L et al (2020) Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry. Ann Rheum Dis -219498. https://​doi.​org/​10.​1136/​annrheumdis-2020-219498
19.
22.
Zurück zum Zitat Alvarez-Hernandez E, Peláez-Ballestas I, Vazquez-Mellado J, Terán-Estrada L, Bernard Medina AG, Espinoza J et al (2008) Validation of the health assessment questionnaire disability index in patients with gout. Arthritis Rheum 15:665–669. https://doi.org/10.1002/art.23575 Alvarez-Hernandez E, Peláez-Ballestas I, Vazquez-Mellado J, Terán-Estrada L, Bernard Medina AG, Espinoza J et al (2008) Validation of the health assessment questionnaire disability index in patients with gout. Arthritis Rheum 15:665–669. https://​doi.​org/​10.​1002/​art.​23575
25.
Zurück zum Zitat Constandt B, Thibaut E, De Bosscher V, Scheerder J, Ricour M, Willem A (2020) Exercising in times of lockdown: an analysis of the impact of COVID-19 on levels and patterns of exercise among adults in Belgium. Int J Environ Res Public Health. 2020:17(11). https://doi.org/10.3390/ijerph17114144CrossRef Constandt B, Thibaut E, De Bosscher V, Scheerder J, Ricour M, Willem A (2020) Exercising in times of lockdown: an analysis of the impact of COVID-19 on levels and patterns of exercise among adults in Belgium. Int J Environ Res Public Health. 2020:17(11). https://​doi.​org/​10.​3390/​ijerph17114144CrossRef
29.
Zurück zum Zitat N ̃amendys-Silv Silvio A, Alvarado-Avila Pedro A., Dominguez-Cherit Guillermo, Rivero-Sigarroa Eduardo Sanchez-Hurtado Luis Et al (2020) Outcomes of patients with COVID-19 in the Intensive Care Unit in Mexico: a multicenter observational study, Elsevier, Heart-Lung, 10-20-2020 https://doi.org/10.1016/j.hrtlng.2020.10.013 N ̃amendys-Silv Silvio A, Alvarado-Avila Pedro A., Dominguez-Cherit Guillermo, Rivero-Sigarroa Eduardo Sanchez-Hurtado Luis Et al (2020) Outcomes of patients with COVID-19 in the Intensive Care Unit in Mexico: a multicenter observational study, Elsevier, Heart-Lung, 10-20-2020 https://​doi.​org/​10.​1016/​j.​hrtlng.​2020.​10.​013
30.
Zurück zum Zitat COVID-ICU Group on behalf of the REVA Network and the COVID-ICU Investigators(2021) Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: a prospective cohort study, Springer,Intensive Care Med, 2021 https://doi.org/10.1007/s00134-020-06294-x COVID-ICU Group on behalf of the REVA Network and the COVID-ICU Investigators(2021) Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: a prospective cohort study, Springer,Intensive Care Med, 2021 https://​doi.​org/​10.​1007/​s00134-020-06294-x
31.
Zurück zum Zitat Joy Mark, Hobbs Richard, Lopez Bernal J., Sherlock Julian, Amirthalingam Gayatri, McGagh Dylan et al (2020) Excess mortality in the first COVID pandemic peak: cross-sectional analyses of the impact peak: cross-sectional analyses of the impact of age, sex, ethnicity, household size, and long-term conditions in people of known SARS-CoV-2 status in England, British Journal of General Practice, December 2020 of an abridged version published inprint. Cite this version as: Br J Gen Pract 2020; https://doi.org/10.3399/bjgp20X713393 Joy Mark, Hobbs Richard, Lopez Bernal J., Sherlock Julian, Amirthalingam Gayatri, McGagh Dylan et al (2020) Excess mortality in the first COVID pandemic peak: cross-sectional analyses of the impact peak: cross-sectional analyses of the impact of age, sex, ethnicity, household size, and long-term conditions in people of known SARS-CoV-2 status in England, British Journal of General Practice, December 2020 of an abridged version published inprint. Cite this version as: Br J Gen Pract 2020; https://​doi.​org/​10.​3399/​bjgp20X713393
Metadaten
Titel
Gout during the SARS-CoV-2 pandemic: increased flares, urate levels and functional improvement
verfasst von
Juan Salvador García-Maturano
David Eduardo Torres-Ordaz
Miguel Mosqueda-Gutiérrez
Citlallyc Gómez-Ruiz
Aarón Vázquez-Mellado
Alicia Tafoya-Amado
Ingris Peláez-Ballestas
Rubén Burgos-Vargas
Janitzia Vázquez-Mellado
Publikationsdatum
25.11.2021
Verlag
Springer International Publishing
Schlagwort
COVID-19
Erschienen in
Clinical Rheumatology / Ausgabe 3/2022
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-021-05994-z

Kompaktes Leitlinien-Wissen Innere Medizin (Link öffnet in neuem Fenster)

Mit medbee Pocketcards schnell und sicher entscheiden.
Leitlinien-Wissen kostenlos und immer griffbereit auf ihrem Desktop, Handy oder Tablet.

Neu im Fachgebiet Innere Medizin

RA-Basistherapie: Neues zu altbekannten Medikamenten

Zu glauben, zur Basistherapie der rheumatoiden Arthritis (RA) mit Methotrexat und Glukokortikoiden sei bereits alles gesagt, hat sich beim diesjährigen Rheuma-Update-Seminar wieder einmal als falsch erwiesen. Sogar eine in der Praxis „viel geübte Strategie“ wurde hinterfragt.

Erhöhte Hypoglykämie-Gefahr nach Beginn einer Betablockertherapie

Beginnen Diabetiker eine Behandlung mit Betablockern, verdoppelt sich in den ersten Wochen fast das Hypoglykämie-Risiko, normalisiert sich mit der Zeit aber wieder. Besondere Vorsicht ist unter einer Therapie mit nichtselektiven Wirkstoffen geboten.

Nierenzellkarzinom: Daten zur Lebensqualität unter HIF-Inhibition vorgelegt

Seit wenigen Wochen ist mit Belzutifan eine neue Wirkstoffklasse beim fortgeschrittenen klarzelligen Nierenzellkarzinom in der EU zugelassen. Frisch publizierte Ergebnisse zur Lebensqualität erweitern jetzt die Datenbasis zur Risiko-Nutzen-Bewertung für den HIF-2α-Inhibitor.

Warum genderspezifische Medizin notwendig ist 

Laut Zahlen der WHO aus dem Jahr 2024 sterben zwei Frauen pro Minute an Krankheiten, die mit geschlechtsspezifischen Faktoren zusammenhängen. Außerdem wirken Medikamente bei ihnen oft anders als bei Männern. Zeit für ein genderspezifisches Denken in der Medizin.

EKG Essentials: EKG befunden mit System (Link öffnet in neuem Fenster)

In diesem CME-Kurs können Sie Ihr Wissen zur EKG-Befundung anhand von zwölf Video-Tutorials auffrischen und 10 CME-Punkte sammeln.
Praxisnah, relevant und mit vielen Tipps & Tricks vom Profi.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.